{"id":"ebba8794-a39c-4a89-81f3-e05ff9b81428","name":"MicroPort MedBot","slug":"microport-medbot","description":"Shanghai MicroPort MedBot (Group) Co., Ltd. (HKEX: 02252) is a surgical robotics company spun out of [MicroPort Scientific](/companies/microport-scientific) in 2015. Its flagship [Toumai](/models/toumai) laparoscopic surgical robot has received regulatory approval in over 60 countries and achieved 100+ commercial orders, making it the leading Chinese-developed surgical robot globally. The company covers five surgical robotics subsectors: endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture.","status":"active","founded":2015,"hq":"Shanghai, China","hqLat":31.2312707,"hqLng":121.4700152,"hqGeocodedAt":"2026-08-05T14:39:07.736Z","hqAddress":null,"hqPrecision":null,"website":null,"fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.medbotsurgical.com/en/news/53.html","title":"MicroPort Toumai Surgical Robot Receives NMPA Approval | MicroPort MedBot"},{"url":"https://microport.com/news/toumai-surgical-robot-achieves-global-commercialization-milestone-with-100-orders","label":"Toumai Surgical Robot Achieves Global Commercialization Milestone with 100 Orders","title":"Toumai Surgical Robot Achieves Global Commercialization Milestone with 100 Orders","mediaType":"article","sourceName":"MicroPort MedBot (official)"},{"url":"https://en.wikipedia.org/wiki/MicroPort","label":"MicroPort - Wikipedia","title":"MicroPort - Wikipedia","mediaType":"article","sourceName":"Wikipedia"}],"keyFacts":[{"label":"CEO","value":"Dr. Chao He (Founder & President)"},{"label":"Stock","value":"HKEX: 02252.HK"},{"label":"Parent","value":"MicroPort Scientific Corporation (00853.HK)"},{"label":"Financial stage","value":"Growth (publicly listed, subsidiary of MicroPort Scientific)"},{"label":"Toumai orders","value":"100+ commercial orders, 80+ installations (Oct 2025)"},{"label":"Countries","value":"60+ countries with regulatory access, ~40 active installations"}],"aliases":["Shanghai MicroPort MedBot","MicroPort MedBot Group"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"02252.HK","stockExchange":"HKEX","secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-27T10:23:59.383Z","updatedAt":"2026-08-05T14:39:07.737Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/microport-medbot","url":"https://registry.deploy.report/companies/microport-medbot","name":"MicroPort MedBot","alternateName":["Shanghai MicroPort MedBot","MicroPort MedBot Group"],"description":"Shanghai MicroPort MedBot (Group) Co., Ltd. (HKEX: 02252) is a surgical robotics company spun out of [MicroPort Scientific](/companies/microport-scientific) in 2015. Its flagship [Toumai](/models/toumai) laparoscopic surgical robot has received regulatory approval in over 60 countries and achieved 100+ commercial orders, making it the leading Chinese-developed surgical robot globally. The company covers five surgical robotics subsectors: endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture.","identifier":"ebba8794-a39c-4a89-81f3-e05ff9b81428","foundingDate":"2015","address":"Shanghai, China","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":["knowledge-base","primary-company-ir"]}}}